On the recordMarch 27, 2017
We heard story after story about venture capital drying up, innovation, medical technology companies launching their products overseas.
Source
congress.govEditor's note · Context
Walden highlights concerns about the impact of regulatory delays on medical innovation.
Share
More from Greg Walden
Nov 17, 2020
I thank my friend and colleague from Illinois for her support of this legislation and her work on it. Once again, I urge passage of the legislation, and I yield back the balance of my time.
Sep 30, 2020
Transitioning to clean energy carries costs that are not always discussed thoroughly to the people that have to pay those costs.
Oct 2, 2020
It does not give me pleasure to be here today to say what I am about to say. I am really frustrated. The Energy and Commerce Committee, which I am the ranking member and former chairman of, we worked most of this year on legislation to ban…
Dec 9, 2020
Before I yield to the author of the bill, the gentleman from Texas, I can tell you, Texas has few stronger advocates, if any, than Mr. Olson. And Texas 22, his congressional district, has had an incredibly effective voice in the United…
Other voices in this conversation
